Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer

被引：0
|
作者：
Erdem Altunel
Roham S. Roghani
Kai-Yuan Chen
So Young Kim
Shannon McCall
Kathryn E. Ware
Xiling Shen
Jason A. Somarelli
David S. Hsu
机构：
[1] Duke University Medical Center,Department of Medicine, Division of Medical Oncology
[2] Duke University,Center for Genomics and Computational Biology
[3] Duke University,Department of Biomedical Engineering
[4] Duke University,Duke Functional Genomics Core
[5] Duke University,Department of Pathology
来源：
BMC Cancer | / 20卷
关键词：
Metastatic colorectal cancer; Patient derived xenograft; High-throughput drug screen; Ponatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Exosome: A megastar of future cancer personalized and precision medicine
    Dhar, Rajib
    Gorai, Sukhamoy
    Devi, Arikketh
    Jha, Saurabh Kumar
    Rahman, Md. Atiar
    Alexiou, Athanasios
    Papadakis, Marios
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2023, 3 (03):
  • [32] Personalized Cancer Models for Target Discovery and Precision Medicine
    Grandori, Carla
    Kemp, Christopher J.
    TRENDS IN CANCER, 2018, 4 (09): : 634 - 642
  • [33] Personalized Preclinical Cancer Models to Guide Precision Medicine
    Pauli, Chantal
    Hopkins, Benjamin D.
    Prandi, Davide
    Shaw, Reid
    Sboner, Andrea
    Sailer, Verena
    Rosati, Rachele
    Pisapia, David J.
    Rao, Rema A.
    Mosquera, Juan Miguel
    Robinson, Brian
    Elemento, Olivier
    Beltran, Himisha
    Dimichelis, Francesca
    Kemp, Christopher
    Grandori, Carla
    Cantley, Lewis
    Rubin, Mark A.
    MODERN PATHOLOGY, 2017, 30 : 461A - 461A
  • [34] Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
    Beltran-Garcia, Jesus
    Osca-Verdegal, Rebeca
    Mena-Molla, Salvador
    Garcia-Gimenez, Jose Luis
    FRONTIERS IN GENETICS, 2019, 10
  • [35] Precision oncology- the future of personalized cancer medicine?
    Ann M. Bode
    Zigang Dong
    npj Precision Oncology, 1
  • [36] Personalized Preclinical Cancer Models to Guide Precision Medicine
    Pauli, Chantal
    Hopkins, Benjamin D.
    Prandi, Davide
    Shaw, Reid
    Sboner, Andrea
    Sailer, Verena
    Rosati, Rachele
    Pisapia, David J.
    Rao, Rema A.
    Mosquera, Juan Miguel
    Robinson, Brian
    Elemento, Olivier
    Beltran, Himisha
    Dimichelis, Francesca
    Kemp, Christopher
    Grandori, Carla
    Cantley, Lewis
    Rubin, Mark A.
    LABORATORY INVESTIGATION, 2017, 97 : 461A - 461A
  • [37] Development of a drug sensitivity testing pipeline towards the establishment of precision medicine for ovarian cancer
    Hirasawa, Akira
    Murum, Astrid Gi
    Yadav, Bhagwan
    Mpindi, John Patrick
    Mariliina, Arjama
    Aittokallio, Tero
    Wennerberg, Krister
    Aoki, Daisuke
    Kallioniemi, Olli
    CLINICAL CANCER RESEARCH, 2013, 19
  • [38] From precision medicine to personalized medicine in metastatic breast cancer patients
    Andre, Fabrice
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [39] Integrated genomics: drug screening and personalized xenograft development approach to identify precision treatments for aggressive pediatric brain tumors
    Tsoli, Maria
    Wadham, Carol
    Pinese, Mark
    Failes, Tim
    Joshi, Swapna
    Mould, Emily
    Yin, Julia
    Gayevski, Velimir
    Kumar, Amit
    Kaplan, Warren
    Ekert, Paul
    Franshaw, Laura
    Gifford, Andrew
    Weber, Martin
    Rodriguez, Michael
    Mayoh, Chelsea
    Cohn, Richard
    Arndt, Greg
    Lock, Richard
    Tyrrell, Vanessa
    Norris, Murray
    Haber, Michelle
    Lau, Loretta
    Dong Anh Khuong Quang
    Wong, Marie
    Trahair, Toby
    Marshall, Glenn M.
    Cowley, Mark J.
    Ziegler, David S.
    CANCER RESEARCH, 2018, 78 (13)
  • [40] Precision medicine for advanced colorectal and gastroesophageal cancer
    Miguel Reyes, Jose
    REVISTA MEDICA CLINICA LAS CONDES, 2022, 33 (02): : 125 - 139
12345